Requena G, Ma L, Sturmer T, Layton JB, DiBello J. Association between an acute, drug-induced decrease in high-density lipoprotein cholesterol levels and risk of cardiovascular events. Clin Drug Invest. 2020 Aug;40:747-54. doi: 10.1007/s40261-020-00935-1
Adelborg K, Rasmussen TB, Norrelund H, Layton JB, Sorensen HT, Christiansen CF. Cardiovascular outcomes and all-cause mortality following measurement of endogenous testosterone levels. Am J Cardiol. 2019 Jun 1;123(11):1757-64. doi: 10.1016/j.amjcard.2019.02.042
Camplain R, Kucharska-Newton A, Keyserling TC, Layton JB, Loehr L, Heiss G. Incidence of heart failure observed in emergency departments, ambulatory clinics, and hospitals. Am J Cardiol. 2018 Jun 1;121(11):1328-35. doi: 10.1016/j.amjcard.2018.02.014
Layton JB, Li D, Meier CR, Sharpless JL, Sturmer T, Brookhart MA. Injection testosterone and adverse cardiovascular events: a case-crossover analysis. Clin Endocrinol (Oxf). 2018 May;88(5):719-27. doi: 10.1111/cen.13574
Camplain R, Kucharska-Newton A, Loehr L, Keyserling TC, Layton JB, Wruck L, Folsom AR, Bertoni AG, Heiss G. Accuracy of self-reported heart failure. The Atherosclerosis Risk in Communities (ARIC) Study. J Card Fail. 2017 Nov;23(11):802-8. doi: 10.1016/j.cardfail.2017.09.002
Rao S, Kshirsagar AV, Layton JB, Brookhart MA. Anticoagulation treatment and management in hemodialysis patients with atrial fibrillation. Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(S2):593.
Layton JB, Wang L, Li W, Yuan J, Setoguchi S. Heat-related outcomes and medication use in older adults with heart failure. Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(S2):185-6.
Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The risk of Achilles or biceps tendon rupture in new statin users: a propensity score matched sequential cohort study. Drug Saf. 2016 Dec;39(12):1229-37.
Layton JB, Hansen MK, Jakobsen CJ, Kshirsagar AV, Andreasen JJ, Hjortdal VE, Rasmussen BS, Simpson RJ, Brookhart MA, Christiansen CF. Statin initiation and acute kidney injury following elective cardiovascular surgery: a population cohort study in Denmark. Eur J Cardiothorac Surg. 2016 Mar;49(3):995-1000. doi: 10.1093/ejcts/ezv246
Hansen MK, Gammelager H, Jacobsen CJ, Hjortdal VE, Layton JB, Rasmussen BS, Andreasen JJ, Johnsen SP, Christiansen CF. Acute kidney injury and long-term risk of cardiovascular events after cardiac surgery: a population-based cohort study. J Cardiothorac Vasc Anesth. 2015 Jun;29(3):617-25. doi: 10.1053/j.jvca.2014.08.020
Hansen MK, Gammelager H, Mikkelsen MM, Hjortdal VE, Layton JB, Johnsen SP, Christiansen CF. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care. 2013 Dec 12;17(6):R292. doi: 10.1186/cc13158
Layton JB, Brookhart MA, Jonsson Funk M, Simpson, Jr RJ, Pate V, Sturmer T, Kshirsagar AV. Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1061-70. doi: 10.1002/pds.3500
Layton JB, Kshirsagar AV, Simpson, Jr RJ, Pate V, Jonsson Funk M, Sturmer T, Brookhart MA. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013 Mar 15;111(6):823-8. doi: 10.1016/j.amjcard.2012.11.047